Conserved Streptococcus pneumoniae surface protein epitopes

Conserved Streptococcus pneumoniae surface protein epitopes are highly conserved antigenic regions located on the exterior of the pneumococcal cell wall, serving as critical targets for next-generation, serotype-independent vaccines and immunotherapies (Pichichero, 2017). These epitopes are found on various virulence factors, including Pneumococcal surface protein A (PspA), Pneumococcal surface protein C (PspC), and Pneumococcal surface adhesin A (PsaA), which are essential for the bacterium's ability to colonize the human nasopharynx and invade sterile sites (Brooks-Walter et al., 1999; Rajam et al., 2008). Biologically, these proteins facilitate host cell adhesion, mediate the acquisition of essential metal ions, and protect the pathogen from the host's innate immune system by inhibiting complement deposition and phagocytosis (Iannelli et al., 2002). In the context of disease, these proteins are instrumental in the pathogenesis of pneumonia, meningitis, and bacteremia by allowing the bacteria to bypass host defenses and proliferate in diverse physiological environments (Converso et al., 2020). Therapeutic strategies targeting these epitopes, such as protein-based vaccines, aim to elicit broad-spectrum immunity that overcomes the limitations of current polysaccharide-conjugate vaccines, which only cover a subset of the over 100 known serotypes (Giefing et al., 2008). By inducing opsonophagocytic antibodies and neutralizing the functional domains of these proteins, these interventions can significantly reduce the global burden of pneumococcal disease.

Other names

Pneumococcal surface proteinsConserved pneumococcal antigensPneumococcal protein vaccine targetsStreptococcus pneumoniae surface antigens

Induction of opsonophagocytic antibodies that facilitate bacterial clearance by immune cells, neutralization of virulence factors to prevent host tissue damage, and inhibition of bacterial adherence to mucosal surfaces.